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Thirty-five Staphylococcus aureus strains, including 10 reference strains and 25 strains recovered from
clinical specimens and food samples, were analyzed by PCR REA (restriction endonucleases analysis) of the
egc operon and spa typing. Nineteen spa types and seven different egc operons, including four putative new egc
variants, were revealed. In 13 strains, allelic variants of sei and/or seg were found. By an analysis of their
nucleotide sequence identities, a new homogeneous cluster of a sei variant, called the sei variant, was detected
in six strains. In addition, the prototype sei was shown to be more polymorphic than assumed so far. Seven
strains possessed the recently described seg variant, also exhibiting several nucleotide exchanges. spa typing
was more effective than REA egc grouping as a typing technique. Since, in some cases, the REA typing method
was able to discriminate strains showing the same spa type, it must be considered for PCR approaches involved
in diagnostic procedures and may be useful for epidemiological studies. Hence, the polyphasic approach used
in this study can be reliably and advantageously applied for typing egc-positive S. aureus strains.
Staphylococcus aureus is an extraordinarily versatile
pathogen causing a wide spectrum of infections, ranging
from mild to severe and life-threatening, in humans as well
as economically important infections in animals. In addition
to superficial lesions and systemic infections, S. aureus is
responsible for toxin-mediated diseases, such as toxic shock
syndrome (TSS) and staphylococcal food poisoning. The
virulence factors causing these toxicoses are members of the
family of bacterial pyrogenic toxin superantigens (PTSAgs)
comprising the TSS-causing toxins and the staphylococcal
enterotoxins (SEs) producing food-borne illness (11, 24).
Superantigens bypassing normal antigen presentation stim-
ulate large populations of T cells by binding to a specific
variable region of the T-cell antigen receptor beta chain
(22). In addition to their nature as superantigens, SEs op-
erate as potent gastrointestinal toxins, causing staphylococ-
cal food poisoning, which has a major public health impact
(18, 28). Approximately 1.5 billion dollars are spent annu-
ally in the United States because of staphylococcal intoxi-
cations (38).
Primarily, five major serological types, SEA through SEE, have
been characterized (6). In the past years, many new types of SEs
and their coding genes (seg through seu) have been reported (12,
16, 17, 19, 27, 30–33, 37, 37, 39, 40). However, some of the novel
SE homologues were shown to be nonemetic, thus actually lack-
ing the defining property of SEs and consequently designated
“staphylococcal enterotoxin-like” superantigens (20). For
SEC, minor variants have been reported (23). The staphylo-
coccal PTSAgs constitute a large family of structurally related
proteins whose genes are associated with mobile genetic ele-
ments. SEB, SEC, SEG, SEI, SEM, SEN, SEO, SEK, SEL,
SEQ, and TSS toxin 1 are encoded by pathogenicity islands
(2, 16, 17, 21). SEA, SEE, and SEP are encoded by pro-
phages (7, 10, 17), whereas SED, SEJ, and SER are encoded
by a plasmid known as pIB485 (3, 29, 40). The association
with mobile genetic elements implies a horizontal transfer
of the PTSAg genes between staphylococcal strains and an
important role in the evolution of S. aureus as a pathogen.
Sequencing of the seg-sei intergenic DNA and flanking re-
gions revealed three enterotoxin-like open reading frames re-
lated to seg and sei, designated sen, seo, and sem, and two
pseudogenes, ent1 and ent2. Moreover, it was shown that
these genes belong to an operon designated the enterotoxin
gene cluster (egc), comprising seo, sem, sei, ent1-ent2, sen,
and seg (16). In addition, minor variants for seg and, limited to
one strain, for sei were reported recently (1, 8). Due to se-
quence divergences in the ent1-ent2 pseudogenes, the seu
gene (including a variant) was described as a further part of the
egc cluster (19). Consequently, at least three different egc sub-
types were suggested: (i) egc1 (harboring seo, sem, sei, ent1,
ent2, sen, and seg), as represented by strain A900322 (Gen-
Bank accession number AF285760), (ii) egc2 (containing seu
instead of ent1 and ent2), as represented by strain FRI 137
(GenBank accession number AY205306), and (iii) egc3 (con-
taining sei, seu, sen, and seg variants), as represented by strain
382F (GenBank accession number AY158703).
Recent studies, comprising isolates recovered from different
human and veterinary specimens, showed that egc and its car-
ried SE genes are more common in S. aureus strains than
assumed so far (4, 5, 15, 26, 36).
Increasingly, S. aureus typing has become an important tool
in the study of strain origin, clonal relatedness, and the epide-
miology of outbreaks. Although several different phenotypic
and, more recently, molecular techniques are available for
differentiating S. aureus strains, no method is clearly superior
under all conditions.
Previous studies (15–16) have shown that egc SE genes are
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arranged in tandem orientation in the egc cluster and are
coexpressed. egc-encoded superantigens from Staphylococcus
aureus are neutralized by human sera much less efficiently than
are classical staphylococcal enterotoxins and toxic shock syn-
drome toxin (14). Moreover SEG and SEI interact differently
with major histocompatibility complex class II and stimulate
completely different subsets of human and mouse T cells.
These characteristics indicate complementary superantigenic
activity and suggest an important advantage to staphylococcal
strains in producing both SEG and SEI.
Therefore, analyzing the diversity of staphylococcal PTSAgs
may enhance our knowledge of the pathogenicity and evolu-
tion of S. aureus and improve detection approaches for diag-
nostic purposes and epidemiological studies.
The purpose of this study was to analyze the genetic
variability within the egc cluster by restriction endonucleases
analysis (REA) and nucleotide sequencing of a collection of
S. aureus strains recovered from different human sources
and food samples. The discrimination power of this tech-
nique was evaluated by comparing its results with those
obtained by spa typing, which is widely used for biotyping S.
aureus strains.
MATERIALS AND METHODS
Bacterial strains. A total of 35 Staphylococcus aureus strains comprising 9
clinical, 16 food-derived, and 10 reference strains (including 4 egc-negative con-
trol strains, DSM 20231T, D 4508, ATCC 14458, and ATCC 27664) were inves-
tigated. The origins and sources of strains are reported in Table 1.
Identification was based on growth characteristics on Columbia agar with 5%
(vol/vol) sheep blood (at 37°C) and positive catalase production. The clinical
TABLE 1. Source, origin and results of egc characterization and spa typing of strains analyzed in this study
Strain Sourceb Originc
PCR result REA egc
group spa typese seu sem-segd
DSM 20231Ta DSMZ Human pleural fluid    t011
D4508a CNTS    t948
ATCC 14458a ATCC Feces of child    t008
ATCC 27664a (FRI326) CNTS Chicken tetrazzini    t029
A900322 CNTS Patient with TSS  e  1 t002
NCTC 9393 CNTS  e  1 t002
RIMD 31092 CNTS MRSA strain  e  1 t002
AS14g DSAN NTS (sample A)  e  1 t209
AS27 DSAN NTS (sample A)  e  1 t209
BS4 DSAN NTS (sample B)  e  1 t209
DS18g DSAN NTS (sample D)  e  1 t209
SI9 DSAN MCM (plant A)  e  1 t164
SI1 DSAN MCM (plant A)  e  1 t164
LA14 DSAN WBRM (plant A)  e  1 t164
R1 DSAN WBRM (plant A)  e  1 t164
ATCC 19095 (FRI137) CNTS Leg abscess    2 t352
382F AFSSA Unspecified (food)    3 t166
ED-3 DSAN RPM (sample ED)  e  4 t078
ED-4 DSAN RPM (sample ED)  e  4 t078
105 DSAT SP (defeathering machine)  e  4 t002
106 DSAT SP (defeathering machine)  e  4 t002
ATCC 25923 ATCC Clinical isolate    5 t021
AB-8802 DSAN RPM (sample AB)    6 t021
7645a IMM HP (osteomyelitis)    7 t021
109 DSAT SP (defeathering machine)    7 t012
OM 56/2a IMM HP (osteomyelitis)    7 t012
K4644/97 IMM HP (blood cultures)    7 t949
K6278/97 IMM HP (blood cultures)    7 t298
A652/99 IMM HP (nasal swabs)    7 t012
A2586/99 IMM HP (nasal swabs)    7 t947
A1048/98 IMM HP (nasal swabs)    7 t363
A2812/98 IMM HP (nasal swabs)    7 t012
A4178/98 IMM HP (nasal swabs)    7 t019
10 DSAT SP (gutting machine)  c () f t267
107 DSAT SP (defeathering machine)  c () f t1059
a egc negative reference strains (used as negative controls).
b ATCC, American Type Culture Collection, Rockville, Md.; AFSSA, Agence Francaise de Se´curite´ Sanitare des Aliments, Maisons-Alfort, France (kindly provided
by P. Fach); DSMZ, Deutsche Sammlung fu¨r Mikroorganismen und Zellkulturen, Braunschweig, Germany; CNTS, Centre Nationale des Toxemies a Staphylococques,
Faculte´ de Medecine Laennee, Lyon, France (kindly provided by G. Lina); DSAN, Dipartimento di Scienza degli Alimenti, Universita` degli Studi di Napoli Federico
II, Portici, Italy; DSAT, Dipartimento di Scienze degli Alimenti, Universita` degli Studi di Teramo, Italy (kindly provided by A. Ianieri); IMM, Institut fu¨r Medizinische
Mikrobiologie, Universita¨tsklinikum Mu¨nster, Mu¨nster, Germany.
c MRSA, methicillin-resistant S. aureus; NTS, “Napoli-Type” salami; WBRM, water buffalo raw milk; MCM, water buffalo Mozzarella cheese manufacturing (natural
whey cultures); RPM, raw poultry meat; SP, slaughterhouse for pigeon; HP, strains were isolated from different patients admitted to the University Hospital of
Muenster (1997–1999).
d PCR using the primer pair SEI-1 (targeting sem) and SEG-2 (targeting seg) covering a 3,375-bp fragment of the egc cluster.
e The size of the amplification band was other than expected.
f (), weak PCR amplification result.
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isolates were identified biochemically by the automated ID 32 Staph system
(bioMe´rieux, France). The presence or absence of bound or free coagulase,
respectively, was confirmed by latex slide agglutination for clumping factor,
protein A, and capsular polysaccharides (Pastorex Staph-Plus; Sanofi Diagnostics
Pasteur, France). For all strains, the S. aureus-specific nuc gene was detected as
previously described (9).
DNA isolation. Following overnight incubation in brain heart infusion broth
(Oxoid, Basingstoke, Hampshire, United Kingdom), staphylococcal cells were
streaked on brain heart infusion agar plates and incubated overnight at 37°C.
DNA extraction was carried out from a single colony by using the InstaGene
matrix (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer’s
recommendations. About 25 ng of DNA was used for PCR amplification.
PCR amplification of the S. aureus egc. The egc operon was detected by using
PCR primers SEI-1 and SEG-2 as previously described by McLauchlin et al. (25)
(Table 2), amplifying a 3,375-bp fragment comprising 47 nucleotides of sem, the
complete nucleotide sequences of sei, ent1-ent2 (or seu), and sen followed by
610 nucleotides of seg.
PCR amplifications were performed in a 50-l total volume, including 5 l of
the target DNA, 5.0 l of Taq DNA polymerase 10 buffer (Invitrogen, San
Giuliano Milanese, Italy), 2.5 l of 50 mM MgCl2, 0.5 l of dNTP mix (25 mM
each), 0.1 l of each primer (0.1 mM), and 0.4 l of Taq DNA polymerase (5
U/l) (Invitrogen). PCR consisted of 30 cycles at 95°C for 10 s and 55°C for 3.5
min and one additional final cycle at 72°C for 10 min. The PCR amplification
fragments were resolved by agarose (1% wt/vol) gel electrophoresis at 100 V for
2 h. The gel was stained with ethidium bromide, and the bands were visualized
under UV illumination at 254 nm.
REA of S. aureus egc cluster. REA of the amplification fragments of the primer
pair SEI-1 and SEG-2 was performed by digestion of about 1 g (30 to 35 l) of
the PCR product with 20 U of the following restriction enzymes (in a total
volume of 50 l): EcoRI, AluI, TaqI, and CfoI (Promega Italia, Milan, Italy).
Restriction digests were resolved by agarose (2% wt/vol) gel electrophoresis at 80
V for 3 h.
PCR detection of the individual SE genes of the egc cluster. seo, sem, sei, sen,
and seg genes were detected by using the following primer pairs: SEO-1 and
SEO-2, SEM-1 and SEM-2, SEI-1 and SEI-2, SEN-1 and SEN-2, and SEG-1 and
SEG-2 (Table 1). The 1-2 pseudogenes and seu were detected by the use of the
primer pairs PSE-1 plus PSE-4 and PSE-2 plus PSE-4, respectively, as previously
published by Letertre et al. (19) (Table 2).
Sequencing procedures of sei, and seg genes. The 3,375-bp SEI-1/SEG-2 am-
plification fragments were used for sequencing the sei and seg genes. In the case
of weak amplification products (Table 3), the primer pairs SEI-1/SEI-4 and
SEG-1/SEG-4 (Table 2) were used alternatively. sei/seg PCR was performed as
described above, while PCR cycling conditions were 94°C for 3 min, followed by
30 cycles of 94°C for 5 s and 53°C for 1 min and finally 72°C for 5 min.
Following purification of the amplification products by using the QIAquick gel
extraction kit (QIAGEN, Milan, Italy), the fragments were sequenced, with the
same primers used for PCR amplification being applied. DNA sequences were
determined by the dideoxy chain termination method using the DNA sequencing
kit (Perkin-Elmer Cetus, Emeryville, CA) according to the manufacturer’s in-
structions. The sequences were analyzed, and the GenBank and EMBL data-
bases were queried by using MacDNASIS Pro, version 3.0.7 (Hitachi Software
Engineering Europe, Olivet, France).
spa typing. The x region of the spa gene was amplified by PCR with primers
1095F and 1517R as previously described by Shopsin et al. (35). DNA sequences
were obtained by an ABI 377 sequencer (Applied Biosystems, Foster City,
Calif.). spa types were determined with the software Ridom StaphType (13) by
using the Ridom SpaServer (http://spa.ridom.de/).
Nucleotide sequence accession numbers. All sequences determined in this
study were deposited in GenBank under accession numbers AY920260, AY920261,
AY920259, AY920257, AY920262, AY920256, AY920258, DQ778337, DQ778338,
AY920264, AY920265, AY920263, AY920269, AY920266, AY920267, and
AY920268.
RESULTS
PCR amplification of the S. aureus egc cluster. Primers SEI-1
and SEG-2 (Table 2) were used to amplify a 3,375-bp fragment
TABLE 2. PCR primers used in this study
Primer Sequence (5-3) egc positiona Reference
SEO-1 AGT CAA GTG TAG ACC CTA TT 494–513 8
SEO-2 TAT GCT CCG AAT GAG AAT GA 1027–1008 8
SEM-1 CCA ATT GAA GAC CAC CAA AG 1544–1563 8
SEM-2 CTT GTC CTG TTC CAG TAT CA 2060–2042 8
SEI-1 GAC AAC AAA ACT GTC GAA ACT G 2087–2108 25
SEI-2 CCA TAT TCT TTG CCT TTA CCA G 2716–2695 25
SEI-4 GCC CTA GAG ACT TTA AAA TT 3002–2983 This study
PSE-1 TGA TAA TTA GTT TTA ACA CTA AAA TGC G 2919–2946 19
PSE-2 TAA AAT AAA TGG CTC TAA AAT TGA TGGb 3278–3289 19
PSE-4 CGT CTA ATT GCC ACG TTA TAT CAG T 3984–3960 19
SEN-1 ATT GTT CTA CAT AGC TGC AA 3818–3837 8
SEN-2 TTG AAA AAA CTC TGC TCC CA 4499–4480 8
SEG-1 TGC TAT CGA CAC ACT ACA ACC 4758–4778 25
SEG-2 CCA GAT TCA AAT GCA GAA CC 5461–5442 25
SEG-4 AGT TCG AAA CGC ACT TTA TG 5674–5655 This study
a According to the sequence of the 6,418-bp DNA fragment of S. aureus A900322 harboring the egc cluster (GenBank accession number AF285760) (16).
b The underlined sequence corresponds to the 15-bp insertion allowing the seu gene.
TABLE 3. PCR egc characterization of strains showing SEI-1/SEG-2 weak amplification bands
Strain Sourcea
PCR resultb
sem-segc se seu seo sem
sei
sen
seg
SEI-1 SEI-2 SEI-1 SEI-4 SEG-1 SEG-2 SEG-1 SEG-4
10 DSAT ()  e       
107 DSAT ()d  e       
a DSAT, Dipartimento di Scienze degli Alimenti Universita` degli Studi di Teramo, Italy (kindly provided by A. Ianieri).
b If not specified, PCR results are based on the use of previously published primer pairs (8, 19, 25).
c PCR using the primer pair SEI-1 (targeting sem) and SEG-2 (targeting seg) covering a 3,375-bp fragment of the egc cluster.
d (), weak PCR amplification result.
e The size of the amplification band was other than expected.
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representing approximately 65% of the nucleotide sequence of
the egc operon. PCR amplification showed the expected frag-
ment in 29 strains, whereas 2 strains (10 and 107) showed
reproducible but weak amplification bands and no amplifica-
tion signal was obtained by the 4 strains used as negative
controls (Table 3).
REA of S. aureus egc cluster. Fig. 1 (panels B, C, D, and E)
shows the different REA patterns of the 29 egc-positive strains
obtained from digestions of the 3,375-bp PCR fragment using
EcoRI, TaqI, AluI, and CfoI. According to the results obtained
by REA, the strains were classified into seven groups (Table 4).
Three groups were associated with strains possessing the pre-
viously described three types of the egc operon (Table 1): (i)
REA-1, comprising A900322 known to harbor egc1, other ref-
erence strains, and food-borne isolates, (ii) REA-2, restricted
to FRI 137 and known to harbor egc2, and (iii) REA-3, re-
stricted to 382F and known to possess egc3. Further REA
groups (Table 1), such as REA-4, found in veterinary and food
origin isolates, REA-5, shown for ATCC 25923, REA-6, ob-
served for AB8802, as well as REA-7, comprising several iso-
lates of human and veterinary origin, represent S. aureus
strains which may harbor putative novel types of the egc
operon (designated egc4, egc5, egc6, and egc7, respectively).
PCR detection of the individual SE genes of the egc cluster.
Applying the primers PSE-2 and PSE-4, which were previously
reported by Letertre et al. (19) to be specific for the detection
of seu, a PCR fragment of the expected length was obtained for
strains belonging to only REA-2, REA-3, and REA-5 to
REA-7, not REA-1 and REA-4 (Table 1). In contrast, a spe-
cific PCR fragment was amplified for all egc-positive strains
using the PSE-1 and PSE-4 primer set (19), flanking a region
covering both the pseudogenes ent1-ent2 and seu, respec-
tively.
Analysis of strains with weak SEI-1/SEG-2 amplicons. The
two strains providing weak SEI-1/SEG-2 amplification results
using primers as previously described (8, 25) tested PCR pos-
itive for seo, sem, and sen, negative for seg and seu, and variable
for sei. Thus, these strains were grouped into two different
toxin genotypes differing in the possession of sei (Table 3).
However, a positive sei PCR result was detected in these
strains by applying SEI-1 (25) in combination with the newly
designed primer SEI-4, which targets an alternative egc posi-
tion. Also, seg tested PCR positive for these strains by using a
further newly designed primer (SEG-4) along with SEG-1 (25).
Sequencing of seg and sei fragments. The sei and seg regions
of strains giving weak amplification results were sequenced and
compared to the sequencing results of the respective sequences
of other strains known to harbor seg and sei (Fig. 2, panel A
and B, respectively). The accession numbers of the sei and seg
gene sequences analyzed in this study are given in Fig. 2.
Dendrograms, as depicted in Fig. 2, demonstrate the relation-
ships of the sequences. In both panels of Fig. 2, strains were
clearly gathered in two separate clusters based on the percent-
age of identities. In addition to the prototype seg and sei,
variant types, called the seg and sei variants, were found for
both genes. Moreover, a low-grade polymorphism was revealed
for seg, the seg variant, and sei, but not for the sei variant. In
particular, two nucleotide changes were found for seg (a G3T
substitution at position 5442 and a A3G substitution at posi-
tion 5450; the nucleotide numbering was previously described
by Jarraud et al. [16]) in strains 10 and 107 in the binding site
of primer SEG-2, explaining the negative amplification results
obtained by the SEI-1/SEG-2 and SEG-1/SEG2 primer sets.
FIG. 1. Specific PCR detection and REA characterization of S. aureus egc. Panel A shows the 3,375-bp PCR fragment obtained by amplifying
the S. aureus egc of strains FRI137 (lane 1), NCTC 9393 (lane 2), RIMD 31092 (lane 3), and AB-8802 (lane 4). Panels B, C, D, and E show different
restriction endonuclease patterns obtained from digestions of the 3,375-bp PCR fragment from egc-positive strains with EcoRI, TaqI, AluI, and
CfoI, respectively. M1, 1-Kb DNA Ladder Plus (Invitrogen SRL); M2, 1-Kb DNA Ladder (Invitrogen SRL).
TABLE 4. REA egc patterns shown by strains of
the same egc group
egc
group
Pattern obtained by
EcoRI AluI I TaqI CfoI
1 A B B A
2 A A A A
3 B B C A
4 A B C A
5 B B C B
6 B C C B
7 B C B B
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Finally, a comparison of amino acid sequences, as obtained
by virtual translation of the corresponding genes, showed that
the SEI variant presents 4 to 5% (10 to 11 amino acids) of
amino acid changes in respect to the SEI of strain FRI 445,
while the SEG variant presents about 4% (7 to 8 amino acids)
of amino acid changes in respect to the SEG of strain FRI 572.
spa typing. A total of 19 spa types were obtained by analyz-
ing the 35 strains included in this study (Table 1). In both
directions, there was no general concordance between the af-
filiation to a REA egc group and the spa type of a given isolate.
On one hand, the strains of the REA egc groups 1 (n  11), 4
(n  4), and 7 (n  10) displayed three, two, and seven
different spa types, respectively. On the other hand, some
strains exhibiting the same spa type were shown to differ by
their REA egc polymorphism. The three reference strains
A900322, NCTC 9393, and RIMD 31092 as well as the two
veterinary strains, 105 and 106, exhibiting the t002 spa type,
fitted into the two different REA egc groups 1 and 4, respec-
tively. Also, the reference strain ATCC 25923, the food-de-
rived strain AB-8802, and the human-derived strain 7645a,
harboring the t021 spa type, were shown to belong to three
different REA egc groups (REA-5, -6, and -7, respectively).
Moreover, in other cases, as expected, strains isolated from the
same source showed the same spa type and REA egc group: (i)
strains AS14 and AS27 were isolated from the same sample A;
(ii) strains SI9, SI1, LA 14, and R1 from the same plant A; (iii)
strains ED3 and ED4 from the same sample ED; and (iv)
strains 105 and 106 from the same machine.
DISCUSSION
Originally, seg and sei genes were identified in two separate
strains (FRI 572 and FRI 445) by Munson et al. (27). Subse-
FIG. 2. Nucleotide sequence identities of seg (panel A) and sei (panel B) genes as analyzed in this study. n.d., not determined; n.g.,
not given.
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quently it was shown that, when present, seg and sei genes
coexist in all clinical isolates of S. aureus examined (4, 15), and
they are arranged in tandem orientation on the same 3.2-kb
DNA fragment (15). Sequence analysis of the seg-sei intergenic
DNA and flanking regions revealed three enterotoxin-like
open reading frames related to seg and sei, formerly designated
sek, sel, and sem, and two pseudogenes, ent1 and ent2, (16).
Furthermore, reverse transcription-PCR experiments revealed
that all of these genes belong to one operon, designated the
enterotoxin gene cluster (egc) (16). To rule out possible con-
fusion with SEs described at the same time (12, 32), the sek and
sel genes were renamed sen and seo, respectively, as published
in a correction note (16).
Mempel et al. showed that egc occurs in about 48% of the
SE-positive S. aureus strains isolated from atopic eczema (26).
Recently, we detected this cluster in S. aureus strains iso-
lated from food samples (8). Moreover, genes of the egc
cluster were found in isolates recovered from nasal and
blood specimens in high percentages (4, 5). Recently, by
applying the microarray technology for simultaneous detec-
tion of the SE genes, Sergeev et al. (34) estimated that about
92% of S. aureus strains contain multiple SE genes (espe-
cially the egc cluster genes). Surveys of the egc distribution
in S. aureus strains of animal origin also demonstrated a
high frequency of egc-like genes (36).
However, based on several studies, it has been assumed that
differences in the possession of individual genes or nucleotide
variations may occur for the SE genes of the egc cluster (4, 5,
8, 14, 16, 19). In particular, Letertre et al. (19) found a 15-bp
insertion in ent1 and some point mutations in both ent1 and
ent2 of the strains FRI 137 and 382F with respect to these two
pseudogenes of strain A900322 originally described by Jarraud
et al. (16). Instead of allowing translation of the pseudogenes
(ent1 and ent2), this insertion allowed a putative 261-nucle-
otide open reading frame (named seu) to be translated (19). In
addition, it was demonstrated that egc of strain 382F is char-
acterized by variants of the sei, seu, sen, and seg genes (19).
This seg allele was shown to be identical to the previously
characterized seg variant (1). A further SEGL29P variant was
reported by Jarraud et al. (16).
We recently showed that some egc-positive strains, derived
from food samples, were negative using PCR assays designed
for sei and/or seg (8). Those strains displayed a egc restriction
pattern compared to those of other egc-positive strains. Partial
nucleotide sequencing of the sei and seg genes in strain AB-
8802 (egc, sei negative, and seg negative) confirmed the
mispriming of both reverse sei primer (SEI-2) and forward seg
primer (SEG-1) used in the PCR amplifications. We also
found that approximately 30% of the S. aureus strains tested
showed a positive sei amplification result by PCR, but they
failed in subsequent hybridization reactions with sei-specific
probes using a generic DNA enzyme immunoassay system (4).
In this study, two strains (10 and 107) of veterinary origin
showed weak amplification using primers SEI-1 and SEG-2 but
tested PCR positive using newly designed egc primers, suggest-
ing that the binding sites of the original primer may be poly-
morphic. The last hypothesis was corroborated by the se-
quence analysis of sei and seg genes of 10 and 107 S. aureus
strains. The full sei gene sequences of AB-8802 and 7645a S.
aureus strains showed 100% identity with the sei variant gene
of strain 382F (GenBank accession number AF064774 [19]),
while their full-nucleotide seg gene sequences displayed 99%
identity (AB-8802) with the seg variant gene as previously de-
scribed by Abe et al. (1).
In addition, we analyzed a part of the egc operon (sem-seg
segment) of food-borne, human, veterinary, and reference S.
aureus strains by REA using EcoRI, CfoI, AluI, and TaqI,
allowing the differentiation of at least seven different egc oper-
ons. Thus, REA of the egc operon was shown to be successful
in typing and analyzing egc-positive S. aureus strains. Sequence
analysis of the putative new egc types may provide further
insight into the evolution of egc, which was recently identified
as a highly prevalent operon of enterotoxin genes, forming a
putative nursery of superantigens in S. aureus.
The high level of polymorphism of the S. aureus egc, as
detected by REA analysis of the SEI-1/SEG-2 PCR fragment
and confirmed by DNA sequencing, was shown. The egc poly-
morphism seems to be unrelated to the evolution of S. aureus,
as demonstrated by spa typing. In addition to the recently
described three egc operons, four further variants were char-
acterized. In particular, a variant of sei, called the sei variant,
detectable in several S. aureus strains was delineated. Further-
more, the previously described seg variant was shown to occur
frequently in a defined S. aureus strain collection. The ob-
served polymorphism was due to point mutations causing loss
or generation of restriction endonuclease sites or DNA inser-
tions as described elsewhere. Moreover, this distinct polymor-
phism may explain the existence of strains possessing only
some of the egc-carried genes or pseudogenes. Furthermore,
failures in the detection of the egc cluster may occur, especially
if the primer pair SEI-1/SEG2 is used. This should be consid-
ered, particularly for PCR approaches for diagnostic purposes
and epidemiological studies, although it may be avoided by the
application of the PSE-1/PSE-4 primers (19), which target re-
gions representing highly conserved parts of the cluster.
During this study, the possibility of exploiting the egc poly-
morphism for epidemiological studies was evaluated by com-
paring results obtained by REA of the egc operon with those by
spa typing. Although more limited than REA by pulsed-field
gel electrophoresis analysis in discriminatory power, spa typing
is often used as a screening method for typing S. aureus strains
due to its shorter turnaround time, ease of use, and inherent
advantages of sequence analysis, storage, and information
sharing (35).
Our results reveal higher discriminatory power of spa typing
in biotyping S. aureus egc-positive strains than that of REA egc.
On the other hand, the REA egc analysis’ capability to discrim-
inate, in some cases, among strains showing the same spa type,
even though they were geographically related, makes it a reli-
able typing tool. Therefore, by using a polyphasic approach,
including both REA of egc and spa typing analyses, the bio-
typing of egc-positive S. aureus strains can be reliably achieved,
furnishing, at the same time, knowledge of great consequence
about the potential toxicity of S. aureus strains.
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